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alopecia areata occurs more commonly in thyroid disease (Muller & Winkelmann 1963 , Morgans 1964 ). There is controversy whether thyroid antibodies occur more commonly in alopecia areata (Cunliffe et al. 1969 , Kern et al. 1973 , Munro & Chanarin 1974 . However, it is of considerable interest that alopecia areata, a disease that currently is thought to be linked with autoimmune disease, has now been established to occur often in a chromosomal abnormality such as mongolism.
Summary
Mongols have been found to suffer from alopecia areata more commonly than would be expected by chance. One thousand individuals with mongolism were examined and 60 were found to have alopecia areata. A control group of subnormal individuals matched for age and sex were examined and only one case of alopecia areata was found. Because autoimmune phenomena are well described in chromosomal abnormalities and alopecia areata occurs more commonly in association with diseases known to be autoimmune, fluorescent antibodies were looked for in the sera of those mongols with alopecia areata. Male mongols with alopecia areata did not have increased incidence of fluorescent antibodies in their sera but 8 out of 23 female mongols (35 %) with alopecia areata had antibodies against thyroid components as compared with 2 out of the 23 The leukocyte migration inhibition (LMI) test was first developed by S0borg & Bendixen in 1967 and since then it has been widely used as an in vitro guide to in vivo cell-mediated immunity.
The test is carried out by taking 30 ml of heparinized venous blood, removing the white cells from the plasma, washing them to remove traces of serum and then packing the cells into capillary tubes by centrifugation. The cell-containing capillary tubes are then mounted in culture chambers, antigen is added and the chambers incubated for 18-24 hours. In control cultures the cells migrate out of the tubes into the chamber fan-wise, while in activated chambers, inhibition of migration occurs if the subject is sensitive to the antigen. The areas of migration are measured by planimetry and a migration index is calculated from the ratio of the area of migration in activated cultures to the area of migration in control cultures. An index of 1.0 indicates no inhibition, while values less than 1.0 indicate inhibition of migration.
Recently this system has been adapted to measure the response to mitogens such as phytohemagglutinin (PHA), as well as to antigens.
Full details of this modification have been published (Morison 1973 (Morison , 1974 . By comparing the response obtained in patients with defective cell-mediated immunity to that in normal controls it has been established that a dose of 5 /-tg/ml of PHA in the culture medium gave good separation between the normal and abnormal subjects. It was suggested that a migration index below 0.3 indicated a normal response to PHA. The results were reproducible and not agedependent. Furthermore an incubation period of six hours gave results comparable to those of twenty-four hours. At either six hours or twentyfour hours the test is of course much quicker than the lymphocyte transformation test.
Response to PHA has been measured in a number of conditions: active sarcoidosis (15 patients), systemic lupus erythematosus (3 patients), Hodgkin's disease (3 patients) and malignant lymphoma (1 patient). All except one patient with systemic lupus erythematosus gave abnormal results with an index above 0.3. One patient with Hodgkin's disease has been considered free of the disease for the past three years and yet still gives a very abnormal result. The influence of transfer factor in the test system has been investigated to assess whether the PHA response in defective patients could be improved. A quantity of transfer factor was prepared from a normally responsive subject according to the method of Lawrence (Lawrence & Al-Askari 1971) and tested in vitro on seven patients with active sarcoidosis, one patient with chronic lymphatic leukemia and one patient with Hodgkin's disease. Six of the seven patients with sarcoidosis showed some improvement towards normal over their previous poor response, as did the patient with chronic lymphatic leukxmia. The patient with Hodgkin's disease was unresponsive both with and without transfer factor. The LMI test is thought to be a measure of cell-mediated immunity and the finding that transfer factor can improve the results when these are defective would support that concept.
PHA is the best known of the mitogens but there are a number of others, including concanavallin A, pokeweed mitogen, and the Gramnegative lipopolysacchides of which E. coli endotoxin is one. It has been shown that PHA and concanavallin A mainly stimulate T lymphocytes, E. coli endotoxin stimulates B lymphocytes and pokeweed mitogen stimulates both B and T lymphocytes (Greaves & Janossy 1972) . Although the other mitogens have similar effects in humans as in animals the Gram-negative lipopolysaccharides have not so far been shown to have any effect in humans.
Therefore in the LMI test concanavallin A and pokeweed mitogen would be expected to have an effect but E. coli endotoxin probably would not, first because the test appears to be a measure of T lymphocyte function and, secondly, in other systems tested it does not have an effect on human cells.
The response to these mitogens has been investigated in ten healthy control subjects. Concanavallin A shows a similar response to that seen with PHA except that, as has been shown in other systems, the response is less marked. Pokeweed mitogen produces very little effect. E. coli endotoxin, perhaps surprisingly, does have some action. With doses ranging from 0.1 ,ug/ml to 500 ,tg/ml a flat curve response was produced which suggests that this is not just a toxic effect. Perhaps, therefore, B cells have some function in the LMI test. Morison The turnover time for the epidermal compartment is the time taken for this to replace itself once. It should not be confused with the cell cycle time, which refers to the germinative cell population and describes the interval between mitosis and the subsequent mitosis in one or both daughter cells (i.e., it is the turnover time for the germinative compartment).
A study by Weinstein & Van Scott (1965) concluded that the turnover time in psoriasis for the epidermal compartment beneath the keratin layer (EBK or viable epidermis) was 2 days. In 1968 Weinstein & Frost stated that the cell cycle time in psoriasis was 37.5 hours and that the S phase (DNA synthesis) duration was 8.5 hours, and M phase (mitosis) 16 minutes only. 
Method
Our method for studying turnover time has been based on accurate determination of the duration of DNA synthesis. A group of 8 patients has been studied. Plaques on the forearms of patients were labelled in eight or more sites with intradermal titrated thymidine (H3T) at the start of the experiment, and skin biopsies, using a 4 mm punch, were performed at set times during the ensuing 24 hours. H3T acts as a 'pulse label' for those cells in S phase at the time of injection (Fig 1) . Subsequently these labelled cells pass through G2 and appear as labelled mitoses (Fig 2) . Biopsy specimens were prepared in the standard histological manner, and autoradiographs were made from 5 ,um sections. From these autoradiographs 'labelled mitoses' curves were plotted for each of the 8 patients studied (Fig 3) . Theoretically, the average duration of DNA synthesis is
